Thursday, May 7, 2026

The Princess Without a Title: Kim Ju-ae Trails in North Korea’s Succession Race

Former lawmaker Tae Yong-ho explains Kim Ju-ae's successor training, noting she hasn't been officially designated as heir yet.

OpenAI Unveils GPT-4.5 for Plus Subscribers Amid Resource Challenges

Sam Altman announces the release of GPT-4.5 for Plus subscribers, highlighting its unique intelligence despite cost-effectiveness concerns.

Kim Jong Un, Putin Reaffirm Commitment to Strengthening Cooperation

Kim Jong Un and Putin discuss strengthening ties and cooperation, reflecting on history and mutual support in a recent phone call.

Health

CG Bio Group Launches Acellular Dermal Matrix-based Product Reallo Inject Fine

CG Bio launches Reallo Inject Fine, an acellular dermal matrix product, enhancing usability for medical professionals and expanding applications.

Ceragem Launches Global Standard for AI Home Healthcare, Accelerates Data Platform Push

Ceragem's new ISO/IEC report sets international standards for integrating home healthcare devices, focusing on user well-being and safety.

Hugel Participates AMWC ASIA & TDAC 2026 at the Taipei International Convention Center, Taiwan

Hugel targets Taiwan's aesthetic market, showcasing products at AMWC ASIA & TDAC 2026, while expanding in Indonesia with educational programs.

L&K BioMed Showcases Innovative Products at the AANS Conference in Texas

L&K BioMed showcased its products at the AANS conference, receiving positive feedback and interest for its cervical products, aiming to expand in the U.S. market.

Seers Signs $14.7 Million Contract with UAE to Supply 105,000 Units over 3 Years

Seers signs a major deal for mobiCARE devices in the UAE, aiming for 50% growth and expansion into Vietnam and beyond.
Latest

Revolutionary mRNA Cancer Treatment Shows 49% Survival Improvement: What You Need to Know

A study shows mRNA-based cancer treatments significantly improve survival rates, marking a breakthrough in precision therapy for melanoma.

Unlocking the Future of Healthcare: How Adaptive Clinical Trials Can Transform Regenerative Medicine in Asia

The article discusses South Korea's efforts to ease regulations on regenerative medicine to improve patient access while addressing significant challenges.

Eli Lilly vs. Novo Nordisk: A $1.2 Billion Bet Reveals Two Very Different Futures for Obesity Drugs

Eli Lilly and Novo Nordisk are pursuing different strategies in the obesity treatment market, focusing on expansion versus core strengths.

Why Ebola Now? SK Bioscience Joins a $30 Million Global Push to Rethink Ebola Vaccine Production

SK Bioscience secures funding to enhance Ebola vaccine production, improving yield and stability for better accessibility amid outbreaks.

Data Control Wars: Orchestra Group Unveils a Sovereign AI Cloud That Ditches Public Providers

Orchestra Group launches a Sovereign AI Cloud Data Center to enhance data sovereignty and control over AI infrastructure for organizations.

Revolutionizing Regenerative Medicine: Rokit Healthcare’s AI Partnership with the UAE’s Leading Healthcare Firm

Rokit Healthcare partners with UAE's largest healthcare firm to expand its AI-driven regenerative medicine in the Middle East and globally.

Unlock Youthful Skin: A Comprehensive Guide to Elabie Premier Fillers Launched in Thailand

Humedics launches Elavie Premier HA fillers in Thailand, marking significant expansion in Southeast Asia with a successful symposium.

Unlocking the Future: How Neuracle Science’s NS101 is Set to Revolutionize Alzheimer’s Treatment by 2030

Neuracle Science aims for a KOSDAQ listing and focuses on developing NS101 for neurological diseases, attracting global interest.

2023 Cancer Statistics: Prostate Cancer Surges to Top Spot Among Men in Korea

Prostate cancer is now the most common cancer in South Korean men, reflecting demographic shifts and improved survival rates.

From Scratch to Success: How Trillion Labs is Redefining AI with Their 70B Parameter Model

Trillion Labs aims to join the government's AI project, showcasing its independent model development and commitment to open-source innovation.

Unlocking Creativity: How Seoul’s Youth Will Benefit from New AI and Robotics Programs

Seoul Science Center partners with Smilegate Future Lab to enhance youth education in robotics and AI through innovative programs.

Nesuparib vs. Traditional Treatments: Will This New Dual-Target Cancer Drug Change the Game for Ovarian Cancer?

Onconic Therapeutics advances Nesuparib into Phase 2 trials for ovarian cancer, aiming to validate a novel re-maintenance therapy approach.

Unlocking Opportunities: 2025 Bio GMP Training Program Launches at Daejeon University

Daejeon University launched the 2025 Winter BioRG Training Program for biopharmaceuticals, featuring industry experts and hands-on sessions.

CKDB-501A vs. Botox: Can CKD BiO’s New Botulinum Toxin Compete in China’s Booming Market?

Jongkundang Bio has successfully completed Phase 3 trials in China's botulinum toxin market, signaling global expansion.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.